At what age can Gravol (dimenhydrinate) be given to children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gravol (Dimenhydrinate) Age Guidelines for Children

Gravol can be given to children starting at 2 years of age, though safety data exists for use in children as young as 6 months in specific clinical contexts.

Age-Specific Recommendations

Children Under 2 Years

  • Dimenhydrinate is generally not recommended for routine use in children under 2 years of age due to limited safety and efficacy data in this population 1, 2.
  • For children under 6 years who experience acute ingestion of at least 7.5 mg/kg of dimenhydrinate, emergency department referral is warranted due to toxicity concerns 1.

Children 2 Years and Older

  • Dimenhydrinate appears to be safe for use in the pediatric population aged 2 years and older 2.
  • The medication can be used for treatment of nausea and vomiting in this age group 2.

Critical Safety Considerations

Pre-Treatment Assessment

  • Identify the underlying cause of vomiting before administering dimenhydrinate, as the drug's effectiveness depends on the etiology 2.
  • Ensure no contraindications or potential drug interactions exist with other medications the child may be taking 2.

Dosing Principles for Children

  • For children under 6 years of age, doses should be carefully calculated based on weight, with particular attention to the 7.5 mg/kg threshold that warrants medical evaluation if exceeded 1.
  • Children 6 years and older who ingest at least 7.5 mg/kg or 300 mg (whichever is less) should be referred for emergency evaluation 1.

Toxicity Monitoring

Symptoms Requiring Emergency Care

  • Any patient experiencing moderate to severe symptoms should be referred to an emergency department, including agitation, hallucinations, abnormal muscle movements, loss of consciousness, seizures, or respiratory depression 1.
  • Mild drowsiness or mild stimulation may be observed at home with close monitoring 1.

Observation Timeframes

  • If a child has no symptoms and more than 6 hours have elapsed since dimenhydrinate ingestion, emergency department referral is not necessary 1.
  • For asymptomatic patients with subtherapeutic doses, home observation with poison center follow-up at approximately 6 hours post-ingestion is appropriate 1.

Important Clinical Caveats

  • Do not induce emesis following oral dimenhydrinate exposure due to the potential for rapid onset of altered consciousness or seizures 1.
  • Activated charcoal should not be administered en route to an emergency department for the same reason 1.
  • While dimenhydrinate is available over-the-counter, its use requires careful consideration of the child's age, weight, and clinical presentation 2.

References

Research

Dimenhydrinate use for children with vomiting.

Canadian family physician Medecin de famille canadien, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.